| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $2,019,696 | 9 | 100 |
| Burns Kristie | Sr. VP Mktg & Clinical Affairs | 0 | $0 | 3 | $454,636 | $-454,636 |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | 0 | $0 | 3 | $492,428 | $-492,428 |
| Dodd Sheri Louise | Chief Executive Officer | 0 | $0 | 3 | $1.07M | $-1.07M |
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the …
Over the last 12 months, insiders at Tactile Systems Technology, Inc. have bought $0 and sold $2.02M worth of Tactile Systems Technology, Inc. stock.
On average, over the past 5 years, insiders at Tactile Systems Technology, Inc. have bought $44,835 and sold $796,702 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,900 shares for transaction amount of $44,835 was made by BURKE WILLIAM W () on 2022‑08‑04.
| 2026-08-10 | Sale | Dodd Sheri Louise | Chief Executive Officer | 10,978 0.0489% | $29.44 | $323,243 | -21.84% | |
| 2026-05-11 | Sale | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | 4,631 0.021% | $24.49 | $113,404 | +1.15% | |
| 2026-02-24 | Sale | Dodd Sheri Louise | Chief Executive Officer | 10,993 0.0497% | $28.94 | $318,144 | -13.30% | |
| 2026-02-24 | Sale | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | 7,701 0.0348% | $28.94 | $222,880 | -13.30% | |
| 2026-02-24 | Sale | Burns Kristie | Sr. VP Mktg & Clinical Affairs | 6,246 0.0282% | $28.94 | $180,764 | -13.30% | |
| 2026-02-23 | Sale | Dodd Sheri Louise | Chief Executive Officer | 15,240 0.0674% | $28.30 | $431,245 | -13.22% | |
| 2026-02-23 | Sale | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | 5,518 0.0244% | $28.30 | $156,144 | -13.22% | |
| 2026-02-23 | Sale | Burns Kristie | Sr. VP Mktg & Clinical Affairs | 4,439 0.0196% | $28.30 | $125,612 | -13.22% | |
| 2026-01-02 | Sale | Burns Kristie | Sr. VP Mktg & Clinical Affairs | 5,139 0.0229% | $28.85 | $148,260 | -5.91% | |
| 2025-08-08 | Sale | Dodd Sheri Louise | Chief Executive Officer | 7,762 0.035% | $12.36 | $95,907 | +111.32% | |
| 2025-05-12 | Sale | Birkemeyer Elaine M. | Chief Financial Officer | 2,921 0.0128% | $9.94 | $29,037 | +136.83% | |
| 2025-05-08 | Sale | Dodd Sheri Louise | Chief Executive Officer | 3,149 0.0137% | $9.83 | $30,955 | +131.24% | |
| 2025-05-08 | Sale | BURKE WILLIAM W | director | 3,300 0.0141% | $9.67 | $31,911 | +131.24% | |
| 2025-02-25 | Sale | REUVERS DANIEL L. | director | 28,338 0.1132% | $14.18 | $401,850 | -5.40% | |
| 2025-02-25 | Sale | Birkemeyer Elaine M. | Chief Financial Officer | 2,066 0.0084% | $14.51 | $29,980 | -5.40% | |
| 2025-02-25 | Sale | Burns Kristie | Sr. VP Mktg & Clinical Affairs | 6,468 0.0262% | $14.40 | $93,160 | -5.40% | |
| 2025-02-24 | Sale | REUVERS DANIEL L. | director | 10,938 0.0448% | $14.55 | $159,147 | -7.18% | |
| 2025-02-24 | Sale | Birkemeyer Elaine M. | Chief Financial Officer | 3,778 0.0156% | $14.70 | $55,538 | -7.18% | |
| 2025-02-24 | Sale | Burns Kristie | Sr. VP Mktg & Clinical Affairs | 4,830 0.0199% | $14.65 | $70,753 | -7.18% | |
| 2024-08-12 | Sale | Ferstler Sherri Lee | Senior VP, Sales | 1,550 0.0065% | $13.07 | $20,263 | +7.02% |
| SODERBERG PETER H | director | 236450 1.0438% | $5.86M | 1 | 0 | +38.26% |
| Moen Brent | Chief Financial Officer | 48760 0.2153% | $1.21M | 1 | 9 | <0.0001% |
| BURKE WILLIAM W | director | 48520 0.2142% | $1.2M | 1 | 15 | +42.19% |
| NIGON RICHARD | director | 16785 0.0741% | $415,932.30 | 3 | 5 | +21.69% |
| Pegus Cheryl | director | 2184 0.0096% | $54,119.52 | 1 | 0 | +77.98% |
| Increased Positions | 104 | +80.62% | 5M | +23.86% |
| Decreased Positions | 56 | -43.41% | 5M | -23.12% |
| New Positions | 52 | New | 3M | New |
| Sold Out Positions | 9 | Sold Out | 563,692 | Sold Out |
| Total Postitions | 177 | +37.21% | 21M | +0.74% |
| Morgan Stanley | $62,831.00 | 10.42% | 2.29M | +1,569 | +0.07% | 2025-09-30 |
| Cadian Capital Management, Lp | $56,328.00 | 9.34% | 2.06M | -253,858 | -10.99% | 2025-09-30 |
| Blackrock, Inc. | $48,425.00 | 8.03% | 1.77M | -5,572 | -0.31% | 2025-09-30 |
| Vanguard Group Inc | $43,154.00 | 7.16% | 1.57M | +44,218 | +2.89% | 2025-09-30 |
| Paradigm Capital Management Inc/Ny | $42,152.00 | 6.99% | 1.54M | -80,200 | -4.96% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $32,639.00 | 5.42% | 1.19M | +24,001 | +2.06% | 2025-09-30 |
| Capitolis Liquid Global Markets Llc | $24,716.00 | 4.1% | 902,062 | 0 | 0% | 2025-09-30 |
| Acadian Asset Management Llc | $23,165.00 | 3.84% | 845,448 | +161,786 | +23.66% | 2025-09-30 |
| Deutsche Bank Ag | $15,815.00 | 2.62% | 577,187 | -41,700 | -6.74% | 2025-09-30 |
| Geode Capital Management, Llc | $15,634.00 | 2.59% | 570,574 | -5,069 | -0.88% | 2025-09-30 |